Skip to main content
DAIKEN MEDICAL CO.,LTD logo

DAIKEN MEDICAL CO.,LTD — Investor Relations & Filings

Ticker · 7775 ISIN · JP3482500000 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2025-11-04 Regulatory Filings
Country JP Japan
Listing T 7775

About DAIKEN MEDICAL CO.,LTD

https://daiken-iki.co.jp/en/

DAIKEN MEDICAL CO., LTD. is a medical device manufacturer that develops, produces, and sells original products. The company specializes in equipment for anesthesia, infection control, and suction applications. Its main product lines include the COOPDECH brand of syringe pumps and patient-controlled analgesia (PCA) devices, alongside various suction systems and endotracheal tubes. The company's approach is based on integrating insights from clinical practice with its research, development, and manufacturing technologies to create advanced medical solutions for the global healthcare market.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 58
2025-11-04 Japanese
半期報告書－第58期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow Statement) for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2026
2025-11-04 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following resolutions made at the Annual General Meeting (AGM) held on June 19, 2025. Section 2 details the resolutions passed, including changes to the Articles of Incorporation, election of directors, and revision of director/auditor compensation. This structure—reporting the results of a shareholder meeting (AGM) via an extraordinary filing—is characteristic of reporting the outcome of a general meeting. The closest specific category for reporting voting results from a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is an 'Extraordinary Report' (which might suggest RNS), the content is specifically about the voting outcomes of the AGM, making DVA the most precise fit.
2025-06-25 Japanese
内部統制報告書－第57期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document explicitly states its title and purpose multiple times in Japanese: "内部統制報告書" (Internal Control Report). The filing details specify the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act ("金融商品取引法第24条の４の４第１項"), and the submission date is June 19, 2025, referring to the fiscal year ending March 31, 2025. This document is a formal report detailing the assessment of internal controls over financial reporting, which aligns with the requirements for an annual internal control report in Japan, often filed alongside the 10-K equivalent or as a standalone requirement. Given the options, this is a comprehensive report on internal controls, which is closest in nature to an Audit Report/Information (AR) or a specific regulatory filing. However, since it is a formal, comprehensive report on internal controls over financial reporting, and not just a general audit opinion or a short announcement, it fits best under the category for formal reports that are not the full Annual Report (10-K) or a simple earnings release. In the context of Japanese regulatory filings, the Internal Control Report is a distinct, mandatory annual filing. Among the provided codes, 'AR' (Audit Report / Information) is the closest fit for a formal, comprehensive report detailing internal control effectiveness, as it covers internal/regulatory stress tests and applied accounting principles/reports, which is conceptually related to the assurance provided by internal control reporting. It is not a 10-K (Annual Report) itself, nor is it a short announcement (RPA/RNS).
2025-06-19 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO of Daiken Medical Co., Ltd. regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2025
2025-06-19 Japanese
有価証券報告書－第57期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of a 10-K annual report. It contains detailed financial statements, business descriptions, and management information for the fiscal year ending March 31, 2025. It is a comprehensive regulatory filing, not an announcement or a summary. FY 2025
2025-06-19 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.